These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3086893)

  • 1. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD
    Prog Clin Biol Res; 1986; 213():343-58. PubMed ID: 3086893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA; López-Gómez C; Villar A; Tomás-Lorente F
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental aldose reductase inhibition by Silybin (preliminary communication).
    Santos J; Mira LB; Freire AM; Azevedo M; Manso C
    Acta Med Port; 1984; 5(4-5):115-7. PubMed ID: 6431756
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential use of aldose reductase inhibitors to prevent diabetic complications.
    Zenon GJ; Abobo CV; Carter BL; Ball DW
    Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts.
    Varma SD; Kinoshita JH
    Biochem Pharmacol; 1976 Nov; 25(22):2505-13. PubMed ID: 825129
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase and the etiology of diabetic cataracts.
    Varma SD
    Curr Top Eye Res; 1980; 3():91-155. PubMed ID: 6807610
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical therapy in the prevention of cataract.
    Brown NA; Bron AJ
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS; Ghosh MN
    Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF; Sharpless NE; Goosey JD
    Prog Clin Biol Res; 1982; 114():243-59. PubMed ID: 6131432
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?
    Frank RN
    Arch Ophthalmol; 1990 Sep; 108(9):1229-31. PubMed ID: 2119167
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetic cataract and flavonoids (first results) (author's transl)].
    Leuenberger PM
    Klin Monbl Augenheilkd; 1978 Apr; 172(4):460-2. PubMed ID: 418268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Kador PF; Kinoshita JH; Sharpless NE
    J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of rat lens aldose reductase by flavonoids-matteucinol and baicalein].
    Li SZ; Mao WS; Du XY; Liang SW; Hu BR; Ma YQ
    Yan Ke Xue Bao; 1987 Jun; 3(2):93-4, 137. PubMed ID: 3149594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.